ACCORD LIPID: Fenofibrates fail to improve cardiovascular outcomes in type 2 diabetics

 
• By Asher Mullard
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Alimentary/Metabolic

More from Therapeutic Category